Company No:
Contents
DIRECTORS | Wiem Gharbi |
Tamar Elise Gomez |
REGISTERED OFFICE | Treviot House |
186-192 High Road | |
Ilford | |
IG1 1LR | |
United Kingdom |
COMPANY NUMBER | 15213676 (England and Wales) |
ACCOUNTANT | Gravita Essex Limited |
Treviot House | |
186-192 High Road | |
Ilford | |
Essex | |
IG1 1LR | |
United Kingdom |
Note | 2024 | |
£ | ||
Fixed assets | ||
Tangible assets | 4 |
|
8,567 | ||
Current assets | ||
Debtors | 5 |
|
Cash at bank and in hand | 6 |
|
2,439,405 | ||
Creditors: amounts falling due within one year | 7 | (
|
Net current assets | 2,374,702 | |
Total assets less current liabilities | 2,383,269 | |
Net assets |
|
|
Capital and reserves | ||
Called-up share capital |
|
|
Profit and loss account | (
|
|
Total shareholders' funds |
|
Directors' responsibilities:
These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Ankar.AI Ltd (registered number:
Wiem Gharbi
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year, unless otherwise stated.
Ankar.AI Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Treviot House, 186-192 High Road, Ilford, IG1 1LR, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of shares that will eventually vest and adjusted for the effect of non-market-based vesting conditions.
Fair value is measured by use of the Black-Scholes pricing model which is considered by management to be the most appropriate method of valuation. The expected life used in the model has been adjusted, based on management’s best estimate, for the effects of non-transferability, exercise restrictions, and behavioural considerations.
Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.
Plant and machinery etc. |
|
|
2024 | |
Number | |
Monthly average number of persons employed by the Company during the year, including directors |
|
Equity-settled share-based payment schemes
The company also operates an unapproved share option scheme. The options are B Ordinary shares granted with a fixed exercise price determined at the grant of the option. The options vest over a period of 3 years following the date of the grant. The options are exercisable until up to the 10th anniversary from the date of grant. Non- Employees are not entitled to dividends until the shares are exercised. Vesting of options is subject to fulfilment of obligations.
Details of the share options outstanding during the financial year are as follows:
2024 | ||
---|---|---|
Weighted Average | ||
Number of share options | Average exercise price (£) | |
Outstanding at beginning of period |
|
|
Granted during the period |
|
|
Outstanding at the end of the period |
|
|
Exercisable at the end of the period |
|
|
Plant and machinery etc. | Total | ||
£ | £ | ||
Cost | |||
At 01 January 2024 |
|
|
|
Additions |
|
|
|
At 31 December 2024 |
|
|
|
Accumulated depreciation | |||
At 01 January 2024 |
|
|
|
Charge for the financial year |
|
|
|
At 31 December 2024 |
|
|
|
Net book value | |||
At 31 December 2024 |
|
|
2024 | |
£ | |
Trade debtors |
|
Other debtors |
|
|
2024 | |
£ | |
Cash at bank and in hand |
|
2024 | |
£ | |
Trade creditors |
|
Other taxation and social security |
|
Other creditors |
|
|
Other financial commitments
2024 | |
£ | |
Commitments in respect of rental |
|